TCM

Tang Capital Management Portfolio holdings

AUM $2.6B
1-Year Est. Return 43.55%
This Quarter Est. Return
1 Year Est. Return
+43.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.6B
AUM Growth
+$619M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
210
New
Increased
Reduced
Closed

Top Buys

1
+$56.8M
2
+$40.8M
3
+$34.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$27.4M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$26.2M

Top Sells

1
+$38.2M
2
+$22.1M
3
+$21.5M
4
CRGX
CARGO Therapeutics
CRGX
+$12.6M
5
ELAN icon
Elanco Animal Health
ELAN
+$11.4M

Sector Composition

1 Healthcare 94.95%
2 Consumer Discretionary 2.06%
3 Technology 1.19%
4 Communication Services 0.91%
5 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
26
ANI Pharmaceuticals
ANIP
$1.84B
$29.1M 1.12%
317,500
INSM icon
27
Insmed
INSM
$43.5B
$28.8M 1.11%
200,000
LEGN icon
28
Legend Biotech
LEGN
$5.2B
$27.1M 1.04%
830,000
BNTX icon
29
BioNTech
BNTX
$23.1B
$26.6M 1.03%
270,000
LQDA icon
30
Liquidia Corp
LQDA
$2.99B
$26M 1%
1,143,759
JAZZ icon
31
Jazz Pharmaceuticals
JAZZ
$10.3B
$25M 0.96%
190,000
NVDA icon
32
NVIDIA
NVDA
$4.43T
$24.4M 0.94%
130,509
VKTX icon
33
Viking Therapeutics
VKTX
$4.36B
$22.9M 0.88%
870,000
+500,000
KROS icon
34
Keros Therapeutics
KROS
$661M
$22.4M 0.86%
1,418,984
NBIX icon
35
Neurocrine Biosciences
NBIX
$15.5B
$21.1M 0.81%
150,000
URGN icon
36
UroGen Pharma
URGN
$1.08B
$19.9M 0.77%
1,000,000
DVAX icon
37
Dynavax Technologies
DVAX
$1.28B
$19.4M 0.75%
1,949,500
META icon
38
Meta Platforms (Facebook)
META
$1.7T
$19.1M 0.74%
26,008
ZYME icon
39
Zymeworks
ZYME
$2.01B
$18.8M 0.72%
1,100,000
GSK icon
40
GSK
GSK
$97.7B
$17.3M 0.66%
400,000
JANX icon
41
Janux Therapeutics
JANX
$993M
$17.1M 0.66%
700,000
+500,000
TVTX icon
42
Travere Therapeutics
TVTX
$3.13B
$16.7M 0.64%
700,000
NUVB icon
43
Nuvation Bio
NUVB
$2.93B
$15.5M 0.6%
4,200,000
+300,000
ADMA icon
44
ADMA Biologics
ADMA
$4.72B
$15.4M 0.59%
1,050,000
NKTX icon
45
Nkarta
NKTX
$128M
$14.6M 0.56%
7,055,576
REPL icon
46
Replimune Group
REPL
$832M
$14.2M 0.55%
3,400,000
+200,000
AVIR icon
47
Atea Pharmaceuticals
AVIR
$248M
$14M 0.54%
4,826,200
-63,000
DSGN icon
48
Design Therapeutics
DSGN
$557M
$13.4M 0.52%
1,780,975
DERM icon
49
Journey Medical
DERM
$215M
$13.2M 0.51%
1,854,596
ABCL icon
50
AbCellera Biologics
ABCL
$1.07B
$13.1M 0.5%
2,600,000
1
2
3 4 5